Immunocore Holdings (IMCR) Tax Rate (2021 - 2026)
Immunocore Holdings (IMCR) posted Tax Rate of 2.27% for Q1 2026, up 102.51% sequentially from 90.33% in Q4 2025, and down 1581.0% YoY from 0.15% in Q1 2025.
Analysis
Immunocore Holdings (IMCR) Tax Rate (2021 - 2026) Analysis & Trends
Immunocore Holdings has reported Tax Rate for 6 years, with the latest figure at 2.27% in Q1 2026.
- Quarterly Tax Rate fell 1581.0% year-over-year to 2.27% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 131.57% (down 13637.0% YoY) and the FY2025 annual result came in at 85.94%, down 8943.0% from the prior year.
- Tax Rate rose to 2.27% in Q1 2026 per IMCR's latest filing, from 90.33% in the prior quarter.
- Over five years, Tax Rate peaked at 164.47% in Q3 2025 and troughed at 90.33% in Q4 2025.
- A 5-year average of 0.44% and a median of 1.61% in 2024 frame the typical range for Tax Rate.
- The widest YoY moves for Tax Rate: up 20785 bps in 2025, down 9456 bps in 2025.
- Over 5 years, Tax Rate stood at 9.12% in 2022, then surged by 353 bps to 23.05% in 2023, then tumbled by 82 bps to 4.23% in 2024, then plunged by 2235 bps to 90.33% in 2025, then jumped by 103 bps to 2.27% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 2.27%, 90.33%, and 164.47% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -16.71% |
| 10 | Immunocore Holdings | 1.86 Bn | 975.23 Mn | 114.84 Mn | -58.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58.37% |
| Mar 31, 2026 | 2.27% |
| Dec 31, 2025 | -90.33% |
| Sep 30, 2025 | 164.47% |
| Jun 30, 2025 | -6.25% |
| Mar 31, 2025 | 18.08% |
| Dec 31, 2024 | 4.23% |
| Sep 30, 2024 | -43.38% |
| Jun 30, 2024 | -14.81% |
| Mar 31, 2024 | -1.66% |
| Dec 31, 2023 | 23.05% |
| Sep 30, 2023 | -23.94% |
| Jun 30, 2023 | -1.14% |
| Mar 31, 2023 | -1.57% |
| Dec 31, 2022 | -9.23% |
| Sep 30, 2022 | -24.96% |
| Jun 30, 2022 | 12.10% |
| Dec 31, 2021 | -0.55% |
| Sep 30, 2021 | 6.59% |